These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 32719264

  • 21. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
    Deutsch BC, Collopy C, Kallogjeri D, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2021 Feb 01; 147(2):182-189. PubMed ID: 33300954
    [Abstract] [Full Text] [Related]

  • 22. Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Chan SL, Ng LS, Goh X, Siow CH, Goh HL, Goh BC, Cheo T, Loh KS, Brunham LR.
    Head Neck; 2018 Jul 01; 40(7):1425-1433. PubMed ID: 29451951
    [Abstract] [Full Text] [Related]

  • 23. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
    Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1393-402. PubMed ID: 15817342
    [Abstract] [Full Text] [Related]

  • 24. A new grading system for ototoxicity in adults.
    Theunissen EA, Dreschler WA, Latenstein MN, Rasch CR, van der Baan S, de Boer JP, Balm AJ, Zuur CL.
    Ann Otol Rhinol Laryngol; 2014 Oct 01; 123(10):711-8. PubMed ID: 24820112
    [Abstract] [Full Text] [Related]

  • 25. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH, Dreschler WA, Balm AJ.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1320-5. PubMed ID: 17418969
    [Abstract] [Full Text] [Related]

  • 26. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
    Theunissen EA, Zuur CL, Józwiak K, Lopez-Yurda M, Hauptmann M, Rasch CR, van der Baan S, de Boer JP, Dreschler WA, Balm AJ.
    JAMA Otolaryngol Head Neck Surg; 2015 Sep 01; 141(9):810-5. PubMed ID: 26291150
    [Abstract] [Full Text] [Related]

  • 27. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
    Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, Au DK, Wu PM, Choy DT.
    Int J Radiat Oncol Biol Phys; 1996 Sep 01; 36(2):281-9. PubMed ID: 8892450
    [Abstract] [Full Text] [Related]

  • 28. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Zhu W, Chen F, Li J, Wang W, Zhang H, Yang G, Zou L, Zhu Y, Yuan W, Ding H, Song X, Wang S.
    Acta Otolaryngol; 2019 Mar 01; 139(3):263-268. PubMed ID: 30870056
    [Abstract] [Full Text] [Related]

  • 29. Decreased hearing after combined modality therapy for head and neck cancer.
    Pearson SE, Meyer AC, Adams GL, Ondrey FG.
    Am J Otolaryngol; 2006 Mar 01; 27(2):76-80. PubMed ID: 16500467
    [Abstract] [Full Text] [Related]

  • 30. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Verkaik RS, Schornagel JH, Balm AJ, Dreschler WA, Rasch CR.
    Radiother Oncol; 2008 Oct 01; 89(1):38-43. PubMed ID: 18706728
    [Abstract] [Full Text] [Related]

  • 31. Audiological profile of patients treated for childhood cancer.
    Liberman PH, Goffi-Gomez MV, Schultz C, Novaes PE, Lopes LF.
    Braz J Otorhinolaryngol; 2016 Oct 01; 82(6):623-629. PubMed ID: 27156673
    [Abstract] [Full Text] [Related]

  • 32. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT.
    Arch Otolaryngol Head Neck Surg; 1997 Sep 01; 123(9):978-81. PubMed ID: 9305250
    [Abstract] [Full Text] [Related]

  • 33. Long-term hearing loss after chemoradiation in patients with head and neck cancer.
    Theunissen EA, Zuur CL, Bosma SC, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer JP, van der Molen L, Rasch CR, Dreschler WA, Balm AJ.
    Laryngoscope; 2014 Dec 01; 124(12):2720-5. PubMed ID: 24964759
    [Abstract] [Full Text] [Related]

  • 34. [Ototoxicity in head and neck cancers after radiotherapy and chemoradiotherapy: From primary prevention to tertiary prevention].
    Espenel S, Garcia MA, Guy JB, Vallard A, Ben Mrad M, Langrand-Escure J, El Meddeb Hamrouni A, Trone JC, Xia Y, Rancoule C, Magné N.
    Cancer Radiother; 2017 Feb 01; 21(1):77-83. PubMed ID: 28189351
    [Abstract] [Full Text] [Related]

  • 35. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.
    Hua C, Bass JK, Khan R, Kun LE, Merchant TE.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):892-9. PubMed ID: 18395355
    [Abstract] [Full Text] [Related]

  • 36. Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation.
    Yilmaz YF, Aytas FI, Akdogan O, Sari K, Savas ZG, Titiz A, Tumoz M, Unal A.
    Otol Neurotol; 2008 Jun 01; 29(4):461-3. PubMed ID: 18520582
    [Abstract] [Full Text] [Related]

  • 37. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ.
    Pediatr Blood Cancer; 2013 Mar 01; 60(3):474-8. PubMed ID: 22744939
    [Abstract] [Full Text] [Related]

  • 38. Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
    Atchariyasathian V, Pruegsanusak K, Wongsriwattanakul S.
    J Laryngol Otol; 2015 Aug 01; 129(8):767-72. PubMed ID: 26112091
    [Abstract] [Full Text] [Related]

  • 39. Effects of Chemoradiation on Hearing in Patients with Head and Neck Malignancies: Experience at a Tertiary Referral Care Hospital.
    Jain A, Banerjee PK, Manjunath D.
    Indian J Otolaryngol Head Neck Surg; 2016 Dec 01; 68(4):456-461. PubMed ID: 27833872
    [Abstract] [Full Text] [Related]

  • 40. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer.
    Burger AVM, Duinkerken CW, van Sluis KE, de Boer JP, Navran A, Lanting CP, Jóźwiak K, Dreschler WA, Balm AJM, Zuur CL.
    Eur Arch Otorhinolaryngol; 2024 Sep 06. PubMed ID: 39242413
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.